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  There have been sporadic reports of non-tuber-
culous mycobacteria (NTM) causing disease in the
early part of this century.isolation of NTM from
patients with pulmonary disease became more com-
mon after sputum culture for the diagnosis of pulmo-
nary tuberculosis had become routine by the 1950s1.
Since then important strides have been made in the
taxonomy and identification ofnon-tuberculous
mycobacteria, as well as clarifying their role as
human pathogens and importance in human pulmo-
       nary disease.It is now well established that mycoba-
  cteria other than mammalian tubercle bacilli and
M.leprae. are important human pathogens.2,3
Various names have been suggested for this group
of organisms such as para-tubercle bacilli, pseudo-
tubercle bacilli, unclassified mycobacteria, anonymous
mycobacteria, atypical mycobacteria, opportunistic
mycobacteria, tuberculoid mycobacteria and myco-
bacteria other than tubercle bacilli (MOTT). The
name non - tuberculous mycobacteria (NTM), now
used by the International Working Group on Myco-
bacterial Taxonomy (IWGMT) is gradually gaining
acceptance among mycobacteriologists.
NTM as human pathogens
Most of the information available now on NTM
infections are from Western Australia, Japan, United
States, England and Wales. NTM which have been
encountered in local lymphadenitis in children are
M.scrofulaceum and M.avium complex followed by
M.kansasii and M.fortuitum complex. Skin and soft
tissue infections like swimming pool granuloma
sporotrichoid, local abscess and Buruli (Bairnsdale)
ulcer are known to be caused by M.mainum, M.fortui-
tum complex and M.ulcerans. M.kansasaii and M.avium
complex followed by M.fortuitum complex a n d
M.marinum are NTM which are involved in skeletal
tissue infection whereas M.avium complex and
M.kansasii followed by M.fortuitum complex and
M.scrofulaceum have been reported in disseminated
infection. NTM which have been isolated from
adults with chronic pulmonary disease are M.avium
complex and M.kansasii followed by M.xenopi,
M.szulgai, M.simiae, M.scrofulaceum and M.fortuitum
(Table 1).
T A B L E - l
SUMMARY OF NTM DISEASES OF MAN’
Disease Common species Others
   Chronic pulmonary diseases in adults M.avium complex M. xenopi
M. kansasii M. szulgai
M. simiae
M. scrofulaceum
M. fortuitum
Local lymphadenitis in children M. scrofulaceum
M. avium complex
M .  k a n s a i i      
M. fortuitum complex
Skin and soft tissue:
Swimming pool granuloma
Sprotrichoid 
Local abscess
Buruli (Bairnsdale) ulcer
Skeletal (bone, joint, tendon)
M. marinum
M. marinum
M. fortuitum complex.
M. ulcerans
M. kansasii
M. avium complex
M. fortuitum complex
M. marinum
Disseminated M. avium complex
M. kansasii
M. fortuitum complex
M. scrofulaceum
* Adopted from Emanuel Wolinsky (1979)1
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NTM associated with human pulmonary disease
Mycobacterium avium complex
(M. avium intracellulare)
M. avium and M. intracellulare strains resemble
each other so closely that the distinction cannot be
made by common laboratory examinations. Seroag-
glutination affords the most useful method of separa-
tion in the laboratory. Anz and associates (quoted
by Wolirsky) studied the relationship between
virulence and serotype among M.avium complex
strains. They found that types 1, 2 and 3 usually
were fully virulent, resembling the classic M.avium
and the others showing variable degrees of virulence
or no virulence were termed ‘intracellulare group’.
A co-operative study of the IWGMT found that
strains could not be differentiated from each other by
numerical analysis.
Mycobacterium kansasii
Strains are easily recognised by their photochromo-
genicity and the appearance of red crystals of ß-caro-
tene on prolonged exposure to light. They must
however be distinguished from other photochromo-
genie strains, namely, M.marinum, M. simiae. M.szulgai
and M.vaccae. M.kansasii characteristically show large
cross bars in acid fast smears of sputum.All strains
appear to have a uniform antigenic structure and
there is only one type by seroagglutination.
Mycobacterium xenopi
It is a scotochromogen producing a yellow pigment
of variable intensity. The optimum temperature for
growth is approximately 43°C.In smears the cells are
long and slender, tapered at both ends and paliisaded.
Beck and Stanford found4 four species specific
antigens and report that the strains were serologically
homogenous.
Mycobacterium szulgai
The strains show strong catalase activity, positive
nitrate reduction test, slow Tween hydrolysis, positive
aryl sulfatase test and a distinctive lipid compound.
It was noted by Wolinsky and reported by Schaefer
and co-workers that many of the strains tested
were scotqchromogenic at 37°C, but photochromo-
genie at 25°C. All strains have the same species
specific antigen and are homogenous by seroagglu-
tination.
Mycobacterium simiae
The species shows positive niacin test, weak
photochromogenicity and strong catalase activity
Strains belonging toserotype 1 are homogenous
in their biochemical reactions whereas serotype 2 
strains are heterogenous.Antigenic cross reactivity  
between strains of M.simiae and M.avium complex
has been noted.
Mycobacterium scrofulaceum
The colonies are smooth and globoid and pigmen-
tation varies from light yellow to deep orange which
usually darkens on prolonged exposure to light.Be-
cause of variable pigmentation of both species and
the similarity of biochemical reactions, surface antigens
and drug resistance, it has been suggested that,
M.scrofulaceum could be classified as a member of
the M.avium complex. A study of the lipids led to
the conclusion that organisms classified as M.scro-
fulaceum should be regarded as pigmented types 
of M.intracellulare.
Riesinkov and Dawson (as quoted by Wolinsky)1
coined the name, MAIS complex, for M.avium-
intracellulare-scrofulaceum. All but a few strains of
M.scrofulaceum may be classified by seroagglutinarion
into one of three types.
Mycobacterium fortuitum complex
(M. fortuitum chelonei)
These strains show rapid growth at temperatures
ranging from 25°C to 40°C. The colonies may be
smooth or rough, or mixtures of both varieties, and
they are usually not pigmented. The aryl sulfatase
test is strongly positive.The nitrate reduction test is
positive in strains of M.fortuitum and negative in
cultures of M.chelonei. Strains of M.chelonei were
homogenous, while two types of M. ortuitum could
be recognised by seroagglutination.
Source of NTM
Numerous studies have shown that the NTM may
be found everywhere in the environment: water,
soil and dust, milk and animals.Most common are
the rapidly growing strains, including M.fortuitum,
and the tap water bacillus, now known as M.gordonae.
M.kansasii, M.xenopi and strains of M.avium-intra-
cellulare-scrofulaceum complex have been isolated
from water. The mycobacteria recovered from raw
milk included rapidly growing strains, M.gordonae,
and strains that resembled M.avium intracellulare
and M.scrofulaceum. Strains of MAIS complex have
also been isolated from soil and dust.Strains of
M.avium and M.scrofulaceum have been shown to
remain viable in the soil for a period of two to four
ears. In another study, 16 species were tested. Those
l
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that were considered to have multiplied in the soil
  included M.fortuitum and M.chelonei. M.szulgai pro-
   bably had multiplied while M.simiae, M.xenopi and
two serotypes of M.intracellulare survived without
apparent multiplication. Strains of the MAIS com-
plex have also been recovered from pigs and cattle.
Transmission
Since the organisms are ubiquitously present in
nature, the environment must be considered as the
source of infection. Evidence for person to person
transmission is wanting and there is no information
so far pointing to a vector.Direct transmission from
animal to human also does not seem to occur.The
distinct geographic patterns of M.kansasii and of
M.avium intracellulare mycobacterioses indicate en-
vironmental origins.There is some evidence for a
mode of dispersal through water.They may also
enter the body through the respiratory tract or from
the stomach and bowel where they are present.
Pathogenicity
Experiments have shown that in general, healthy
animals are quite resistant to infection by NTM and
special procedures have to be adopted to produce
lesions of any magnitude in the experimental animals.
Because NTM are widespread and may colonise a
person for a short or long period of time, a fundamental
question arises as to how and when such organisms
produce disease in humans.The possibilities are (1)
their infectivity dose may be very large and small
numbers may not be able to produce disease.Evi-
dence for this is lacking; (2) long standing coloni-
sation may eventually result in invasion. Evidence for
this is very scanty; and (3) some alteration in the host
   defence mechanism, either locally or throughout the
  host immune system, may take place either on a
temporary or permanent basis.There is some evi-
dence for this last possibility.
Some predisposing conditions to invasion by NTM
have also been investigated. Most of the reports
emphasise that NTM pulmonary disease usually
occurs in middle-aged men who have some chronic
lung disease. Pre-existing pulmonary lesions are
noted in most of the cases of M.fortuitum chelonei.
M.scrofulaceum, M. avium intracellulare andM.kan-
sasii disease. It must be emphasised, however,
that cases do occur in women, in younger men, and
in middle aged men without apparent lung disease or
deficiency of cellular immunity.
NTM disease of the lung, like tuberculosis, seems
to select the upper lobes, the main route of infection
being hematogenous seeding of upper lobes from a
primary site or lymph nodes, However, the evidence
is scanty regarding inhaled and aspirated myco-
bacterial particles settling in the upper lobes. These
mycobacteria apparently prefer the higher oxygen
tension in the upper lobe alveoli, There exists some
experimental evidence for the possibility that a failure
or overloading of the clearing mechanisms may be
basic to the development of pulmonary mycobacterio-
sis in humans. The other suggested alternative cause
is the less efficient clearing mechanisms of the upper
lobe.
Diagnosis of NTM pulmonary disease
In tuberculosis, recovery of M.tuberculosis from
the patient is generally equivalent to diagnosis of
disease as no true carrier stage exists. NTM, on
the other hand, are environmental saprophytes and,
in terms of their total numbers, only a very minute
proportion is ever involved in disease process. Hence,
criteria for diagnosis of pulmonary disease due to
NTM are rather more strict than for tuberculosis.
The American Thoracic Society has given the
following criteria for diagnosis of disease due to NTM:
1. “Evidence such as infiltrate, visible on chest
skiagram of disease, the cause of which has not been
determined by careful clinical and laboratory studies;
and
2. Either (a) isolation of the same strain of myco-
bacteria repeatedly, usually in the absence of other
pathogens, or (b) isolation of the same strain of
mycobacterium from a closed lesion from which the
specimen has been collected and handled under sterile
conditions, for example, an abscess or biopsy tissue.
Occassional isolation of these organisms from sputum,
throat washings and gastric aspirates in the absence
of related disease may occur and are not considered
significant diagnostically”.
Pulmonary disease due to NTM in other
countries
In the USA, a 1979 surveys of 49 public health
laboratories showed that M.tuberculosis is the most
commonly isolated mycobacterial species of clinical
significance followed by M.avium complex and M.
fortuitum complex. M.kansasii and M.scrofulaceum
accounted for three percent and two percent
of the isolates respectively.Among saprophytic
species M.gordonae was isolated most often. In
Japan, although the incidence of lung disease
due to M.tuberculosis is steadily decreasing, the
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incidence of lung disease due to NTM has re-
mained almost at the same level over the years.
The non-tuberculous mycobacteria that cause disease
most frequently belong to the M.avium-intracellulare
complex. In a recent report by Tsukamura, et al6 in
537 cases of disease due to non-tuberculous myco-
bacteria, 89.6% was due to M.avium-intracellulare
followed by M.kansasii (8%) and M.fortuitum (1.3%).
He estimated that the incidence of lung disaese due
to non-tuberculous mycobacteria in Japan to be 0.9 to
1.9 per 10 population per year in 1971-1979.More
or less similar distribution of pathogenic strains were
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studies 25 (0.45%) repeatedly excreted organisms
that were not typical human tubercle bacilli; 14 excreted  
NTM from the start indicating primary infection with
absence of bacteriological evidence ofisolation
of M.tuberculosis and 11 had lesions colonised with
NTM following a period of quiescent pulmonary  
tuberculosis. Among patients with probable primary
disease due to NTM, 10 out of the 14 yielded photo-
chromogens and four were non-chromogens, and in
patients with probable colonisation of quiescent
lesions, three yielded Photochromogens, one scotochr-
omogen and seven non-chromogens (Table 3).
TABLE–2
PULMONARY DISEASE DUE TO NTM SUMMARY OF REPORTS FROM WORKERS IN INDIA*
References Region
Mahapatra (1961) Lucknow
Thomas et al (1961) Madras
Kaur Chitkara (1964) Delhi
Bhathena et al (1964) Delhi
Kulkarni Moller (1971) Madanapalli
Lal et al (1972) Delhi
Saran (1973) Patna
Mukhopadyaya (1979) Madanapalli
No. of cultures tested NTM Isolates
125 5
287 –
50 10
28 1
– 4
280 32
100 2
43929        5
Major type
Non-chromogens
–
Non-chromogens
Scotochromogens
Battey type
Non-chromogens
Photochromogens
M. interacellulare
* Adopted from Ramakrishnan (1961)9
isolated in Western Australia and in many centres in
Europe including England.
Pulmonary disease due to NTM in India
From India, there are only very few documented
case reports available so far.Between the years
1961-1979, eight such reports have been published
by Indian workers. Three groups reported non-
chromogens as the major type, while each of the
rest reported non-chromogens, M. intracellulare.
Battey type photochromogens and scotochromogens
as the major type respectively (Table 2).
Study of NTM pulmonary disease from
the Tuberculosis Research Centre (TRC),
Madras
Pulmonary disease due to NTM spanning more
than two decades upto 1979 has been reported
from TRC, Madras9. Out of a total of 5,435
patients admitted to 12 successive chemotherapy
TABLE 3
PULMONARY DISEASE DUE TO NTM
(TRC RETROSPECTIVE STUDY)
Early excretors   Late excretors
Age Males Females Males Females Total
> 30 1 1 2 3 7
31-39 6 1 0 2 9
< 40 5 0 2 2 9
Photochromogens 10 3 13
Scotochromogens – 1 1
Non-chromogens 4 7 11
Total 14 11 25
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Failure to respond to treatment with standard drugs
    occurred in nearly 50% of patients as evidenced by
absence of radiographic improvement and persistent
sputum positivity.There were 10 deaths among the
25 patients. There is some evidence to show that
rifampicin containing regimens could be beneficial
from the therapeutic point of view in the treatment of
some of the cases with disease due to NTM (Table 4).
TABLE 4
NTM PULMONARY DISEASE-RESPONSE TO
TREATMENT
(TRC RETROSPECTIVE STUDY)
Response Early excretors Late excretors Both groups
Good 4 3 7
Poor 8 3 11
Not assessable 2 5 7
Total 14 11 25
A later study conducted in 1981 by Paramasivan
et al7 has shown that non-tuberculous mycobacteria
(NTM) were obtained from 8.6% of 16,907 sputum
specimens in a trial in the Chingleput district of
Tamil Nadu to test the efficacy of BCG vaccination in
the prevention of tuberculosis However, only 0.6%
of 672 autoclaved specimens cultured as part of a
quality control procedure yielded positive cultures of
NTM. This finding substantiates that the NTM
were truly derived from the sputum of the BCG trial
subjects. The mycobacterial species could be identi-
fied in 966 (96.6%) of the first 1000 isolates of NTM;
54.6% were potential pathogens and 73.0% were slow
growing. The species isolated most frequently were
M.avium intracellulare (22.6% of all NTM). M.terrae
(12.5%) and M.scrofu/aceum (10.5%).
Treatment of NTM pulmariary disease
Treatment depends on the site and extent of
  disease due to NTM and the nature of infecting
organisms. M. kansasii is generally susceptible to
    most of the anti-tuberculosis drugs and sputum con-
version occurs in 4-6 months in 96% of patients,
comparable to that of patients with M. tuberculosis.
However, the picture is different with infection
caused by the M. avium intracellulare group. A high
proportion of organisms are resistant in vitro to
isoniazid, PAS, rifampicin, ethambutol and strepto-
mycin. Often, however, the resistance is not total.
Susceptibility to ethambutol and cycloserine is reported
frequently. Lester, a pioneer in this field suggests
5-drug combination with capreomycin.Other drugs
that may occasionally have a place in combination
are kanamycin, erythromycin and pyrazinamide.Since
medical treatment is so unsatisfactory, surgical inter-
vention may have to be considered in patients who
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fail to respond to chemotherapy, within a period of
six months.
In 30% of patients with acquired immune deficiency
syndrome (AIDS) M. avium intrecellulare has heen
isolated and followed at National Institute of Health
(NIH), USA, and in these patients therapy consisting
of conventional anti-tuberculous drugs has been
almost invariably ineffective.Over 90% of the
 clinical isolates have been resistant to isoniazid,
rifampicin and streptomycin.While ansamycin and
clofazimine each show excellent i  vitro activity, a
two-drug regimen using ansamycin 150 mg and
clofazimine 100 mg per day, respectively, has not
been clinically effective. Some success has been
reported for multiple drug regimens that include third
generation cephalosporine or amikacins.
Conclusion
Assuming that most of the NTM originate from
sputum specimens,are they chance contaminants
from the environment,do they colonise the respira-
tory tract and are they responsible for clinical disease?
If NTM, isolated from 4.5% of the sputum specimens
of patients examined in Madras City and Bangalore
was often responsible for clinical disease, this would
have been noted in the reports of the chemotherapy
studies. However, as reported by Ramakrishnan9
only 21 (0.4%) of a total of 4943 patients in 12
chemotherapy studies between 1958 and 1978 yielded
NTM on repeated occasions and of these only 12
yielded NTM without M. tuberculosis on admission
to the study suggesting that disease due to NTM
is rare. By contrast, NTM isolated in technically
advanced countries, where the prevalence of tuber-
culosis is low, are more often the cause of disease.
NTM isolates from Indian patients, in general
appear to be either occuring ascontaminants
or organisms that colonise the respiratory tract over a
period without pathological significance. The dis-
tinction between these two possibilities can only be
made by further studies on the isolation in pure
culture of a particular species of NTM from serial
sputum samples from the same patient.
TABLE 5
ISOLATION OF NTM FROM SAMPLES OBTAINED
IN DIFFERENT STUDIES DURING 1981
Study Area
Total number Specimens with growth of
of specimens NTM on one or both slopes
processed No. %
Trivellore 16907 1457 8.6
Tambaram 3576 270 7.6
Madras City 24121 1095 4.5
Bangalore City 12909 587 4.5
Hona Kona 12830 334 2.6
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TABLE-6
Growth
rate
SPECIES LEVEL IDENTlFlCATlON OF 1000 NTM STRAINS FROM THE BCG TRIAL AREA
Potential pathogens Isolates Non-pathogens Isolates
Species No. % Species No. %
slow
rapid
M. avium/intracellulare
M. scrofulaceum
M. asiaticum
M. marinum
M. malmoense
M. kanasasii
M .  s z u l g a e       
M. heemophilum
M. xenopi
M. ulcerans
M. simiae
Total
M. fotuitum
M. chelonei
Total
Total pathogens
226
105
15
10
9
7
6
5
5
1
396
76
55
131 24.9
527 100.0
Not identified 34
42.9
19.9
2.8
1.9
1.7
1.3
1.3
1.1
0.9
0.9
0.2
75.1
14.4
10.4
M. terrae complex 125 28.5
M. flavescens 67 15.3
M. gordonae 66 15.0
M. triviale 33 7.5
M. gastri 18 4.1
M. nonchromogenicum 0 0.0
Total 309 70.4
M. vaccae 54 12.3
M. phlei 34 7 . 7     
M. smegmatis 19 4.3
M. toakienses $ 11 .5
M. aurum 5 1.1
M. thermoresistable 2 0.5
M. aichiense $ 2 0.5
M. parafortuitum 1 0.2
M. neoaurum 1 0.2
M. fortuitum/ (thermophium) 1 0.2
Other species† 0 0.0
Total 130 29.6
Total non-pathogens 439 100.0
$ classified according to Tsukamura, but their taxonomic position is unsettled.
† M. chitae. M. gadium. M. gilvum. M duvalii
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